6
Oct
2026
AGC Pharma Chemicals
Exhibitor at CPHI Milan 2026 stand 6K18, Contract Manufacturing & Services
About Us
Categories
-
Country/Region:Spain
-
On CPHI since:2020
-
Employees:250 - 499
Company types
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 6K18, Contract Manufacturing & Services
Products Featured at CPHI Milan 2026
-
Product Telmisartan
Active Pharmaceutical Ingredient. Hypertension indication. Cardiovascular therapeutic area. -
Product Mexiletine hydrochloride
Active Pharmaceutical Ingredient. Arrhythmia indication. Cardiovascular therapeutic area. -
Product Gliquidone
Active Pharmaceutical Ingredient. Low blood sugar indication. Metabolic therapeutic area. -
Product Dipyridamole
Active Pharmaceutical Ingredient. Stroke prevention indication. Cardiovascular therapeutic area. -
Product Pirenzepine
Active Pharmaceutical Ingredient. Gastric ulcers indication. Gastrointestinal therapeutic area.
AGC Pharma Chemicals Europe, S.L.U. Resources (1)
-
Video The first choice CDMO for small molecules API in Europe
AGC Pharma Chemicals Europe is part of the Life Science Business of the AGC Group. It is located in Barcelona, Spain, and provides CDMO services, producing small molecules APIs, from kilo to commercial scale.
AGC Pharma Chemicals Europe has one mission: to improve people's life by bringing our best quality products.
We aim to be the first choice CDMO for customers by excelling our top pharma quality, development capability, supply reliability, and sustainability.
Come and discover what AGC can do for you!




